Headlines Flash

Tue, Aug 25 03:10 AM

FDA approves J&J’s Imaavy for rare blood disorder treatment

Investing.com•Mon, Aug 24, 2026, 11:16 PM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Investing.com](https://www.investing.com/news/company-news/fda-approves-jjs-imaavy-for-rare-blood-disorder-treatment-93CH-4874292)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Investing.com ↗

#health #fda #approves #imaavy #rare #blood #disorder #treatment

More Headlines

TechnologyHacker News• 28m ago

FDA approves first Alzheimer's blood test for Americans as young as 40

1 points, 1 comments on Hacker News

SportsYahoo Sports• 1h ago

Mike Vrabel Gives Christian Gonzalez Health Update for Patriots Week 1 Game

The Patriots have an early update for Christian Gonzalez.

TechnologyHacker News• 2h ago

The Great Blood Pressure Scam – By a Midwestern Doctor

1 points, 0 comments on Hacker News

EntertainmentRolling Stone• 2h ago

Taylor Swift Talks Honoring Her Country Roots ‘More and More’ in Rare Interview

The superstar spoke with Recording Academy CEO Harvey Mason Jr.

HealthCBS News• 2h ago

Doctor fact-checks Dr. Oz's comments about vaccines, drug prices

CBS News medical correspondent Dr. Céline Gounder breaks down some of the claims made Sunday on "Face the Nation" by Dr. Mehmet Oz, administrator of the U.

SciencePhys.org• 3h ago

Blood-clotting protein may be SARS-CoV-2's hidden accomplice, helping it hide from antibodies and reach blood vessels

Fibrinogen, the abundant plasma protein best known for forming blood clots, may play a second and far less benign role during SARS-CoV-2 infection: acting as a molecular bridge that simultaneously hides the virus from neutralizing antibodies and delivers it to the cells lining blood vessels.